What is trifluoperazine?

trifluoperazine belongs to a group of drugs known as phenothiazins and is often used to treat schizophrenia or other forms of psychosis. Doctors can prescribe medicines for patients who require anxiety treatment, but generally only if other wording proves unsuccessful. When used for anxiety disorders, treatment is usually only for a short time, because trifluoperazine has the potential for serious and toxic adverse effects.

Scientists believe that trifluoperazine function blocks two of the five dopamine receptors found in smooth muscles throughout the body. These areas include blood vessels, brain and lungs along with gastrointestinal and urinary system. Dopamine acts as a neurotransmitter and is a precursor of hormones epinephrine and norepinephrine, also known as adrenaline. By blocking the development of these hormones, anti -nereggic and anticholinergic activities generally occur, resulting in the trelamic muscles. Changing these receptors in the brain usually causes changes in behavior and thought PROOCHESECH.

Chemical changes that occur in the brain caused by trifluoperazine usually calm mood and improve motivation. These effects of the drug reduce the symptoms of the disease by minimizing the delusion, hallucinations and self -assembly symptoms often associated with the disorder. The calming effect of anti-psychotic drugs also minimizes violent behavior in schizophrenic patients and in patients suffering from other psychotic disorders. Effective treatment of psychosis or schizophrenia usually involves long -term use to minimize symptoms and prevent exacerbation or recurrence.

The common adverse effects of trifluoperazine include dizziness, drowsiness and dry mouth. Patients can also experience anorexia, amenorrhea and blurred vision along with insomnia and muscle weakness. Dopamine reduction can also cause Parkinsona symptoms or a condition known as tardive dyskinesia. This syndrome youThe face of involuntary movements generally observed in the face, mouth and limbs. Patients may experience uncontrolled drooling, chewing or unusual tongue movements. They can walk with a mixing walk and seem to roll something between their fingers.

Tardive symptoms of dyskinesia could be relieved by a reduced dose of the drug, but as soon as it is started, the behavior continues even if the doctor ends trifluoperazine. The drug can also inhibit the development of red and white blood cells, in addition to platelets, causing various anemia. People may experience abnormal heart rhythms or fluid retention. Fluid retention in the brain could cause seizure activity, exacerbation of symptoms or upside down. Trifluoperazine COULD also produces endocrine or genitourinary disorder or causes liver damage.